Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
Globe Newswire•29/07/2026•07:00 ET
0
Whiz Insights
WARREN, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the second quarter ended June 30, 2026, and provide an update on recent developments in its business after market close on Tuesday, August 11, 2026.
Management will host a conference call for investors at 8:00 a.m. ET on Wednesday, August 12, 2026. To participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.
Get started
Create a free account to read the full story.